Credentialing & Privileging

New stent leaves after the work is done

Credentialing Resource Center Connection, April 9, 2009

Want to receive articles like this one in your inbox? Subscribe to Credentialing Resource Center Connection!

Coronary stents save lives, but they leave behind metal scaffolding in a way cardiologists say is like leaving on a cast long after a bone has healed, according to a March 31 article in Technology Review. That same scaffolding can occasionally cause immune reactions, blood clots, and interfere with future surgeries.

A new fully-absorbable stent being developed by Illinois-based Abbott Laboratories solves that problem, according to the article.

“Abbott's new bioabsorbable everolimus-eluting stent, or BVS, is made up of two layers of a biodegradable polymer: one that contains the immunosuppressant drug everolimus, the other forming a longer-lasting backbone. Over time, the body breaks down and absorbs the polymer, ultimately leaving nothing behind,” the article states.



Want to receive articles like this one in your inbox? Subscribe to Credentialing Resource Center Connection!

Most Popular

Related Articles